# Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prednisone-plus-cabazitaxel-or-mitoxantrone-for-metastatic-castration-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johann S. de Bono,Stéphane Oudard,Mustafa Özgüroğlu,Steinbjørn Hansen,Jean-Pascal Machiels,Ivo Kocák,Gwénaëlle Gravis,I. Bodrogi,Mary J. MacKenzie,Liji Shen,Martin Roessner,Sunil Gupta,Oliver Sartor |
| Citations | 3,299 |
| DOI | 10.1016/s0140-6736(10)61389-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2123526148 |
| PMID | 20888992 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Johann S. de Bono](https://scholariq.org/researchers/johann-s-de-bono/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer, Stress, Anesthesia, and Immune Response](https://scholariq.org/topics/cancer-stress-anesthesia-and-immune-response/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.